SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-23-096273
Filing Date
2023-12-18
Accepted
2023-12-18 06:05:19
Documents
4
Period of Report
2023-12-29

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT def14a1223_bimiinter.htm DEF 14A 696912
2 GRAPHIC tproxy_001.jpg GRAPHIC 1273323
3 GRAPHIC tproxy_002.jpg GRAPHIC 1467508
4 GRAPHIC tproxy_003.jpg GRAPHIC 834747
  Complete submission text file 0001213900-23-096273.txt   5623810
Mailing Address 725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK NY NEW YORK
Business Address 725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK NY NEW YORK 212-542-0028
BIMI International Medical Inc. (Filer) CIK: 0001213660 (see all company filings)

IRS No.: 020563302 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34890 | Film No.: 231492169
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
(CF Office: 07 Trade & Services)